Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

In late 2019 SARS-CoV-2 rapidly spread to become a global pandemic, therefore, measures to attenuate chains of infection, such as high-throughput screenings and isolation of carriers were taken. Prerequisite for a reasonable and democratic implementation of such measures, however, is the availabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Midori, Ceren Ates, H., Glatz, Regina T., Mohsenin, Hasti, Schmachtenberg, Rosanne, Göppert, Nathalie, Huzly, Daniela, Urban, Gerald A., Weber, Wilfried, Dincer, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643339/
https://www.ncbi.nlm.nih.gov/pubmed/36405570
http://dx.doi.org/10.1016/j.mattod.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643339/
https://www.ncbi.nlm.nih.gov/pubmed/36405570
http://dx.doi.org/10.1016/j.mattod.2022.11.001

Ejemplares similares